CHAIN 1 341 Cyclic AMP-responsive element-binding
protein 1.
/FTId=PRO_0000076597.
DOMAIN 101 160 KID.
DOMAIN 283 341 bZIP.
REGION 284 309 Basic motif (By similarity).
REGION 311 332 Leucine-zipper (By similarity).
SITE 314 314 Required for binding TORCs.
MOD_RES 111 111 Phosphoserine.
MOD_RES 119 119 Phosphothreonine.
MOD_RES 133 133 Phosphoserine; by CaMK1, CaMK2, CaMK4,
PKB/AKT1 or PKB/AKT2, RPS6KA3, RPS6KA4,
RPS6KA5 and SGK1.
MOD_RES 142 142 Phosphoserine; by CaMK2 (By similarity).
MOD_RES 271 271 Phosphoserine; by HIPK2.
CROSSLNK 285 285 Glycyl lysine isopeptide (Lys-Gly)
(interchain with G-Cter in SUMO1).
CROSSLNK 304 304 Glycyl lysine isopeptide (Lys-Gly)
(interchain with G-Cter in SUMO1).
VAR_SEQ 88 101 Missing (in isoform CREB-B).
/FTId=VSP_000596.
VAR_SEQ 162 272 Missing (in isoform 3).
/FTId=VSP_043914.
VARIANT 116 116 D -> G (found in a patient with multiple
congenital anomalies; does not affect
CREB1 phosphorylation at S-133; fails to
interact with CREBBP).
/FTId=VAR_068077.
MUTAGEN 133 133 S->A: Does not interact with TOX3 and
inhibits induction of transcription by
TOX3. Loss of phosphorylation by CaMK4.
MUTAGEN 155 155 K->R: No effect on sumoylation.
MUTAGEN 271 271 S->A: Impaired phosphorylation by HIPK2
and subsequent transactivation.
MUTAGEN 271 271 S->E: Potentiated transactivation.
MUTAGEN 285 285 K->R: Decreased sumoylation, in vivo and
in vitro.
MUTAGEN 304 304 K->R: Decreased sumoylation, in vivo and
in vitro. Loss of nuclear localization.
CONFLICT 4 4 E -> D (in Ref. 5; CAA42620).
CONFLICT 8 8 E -> D (in Ref. 5; CAA42620).
CONFLICT 160 160 T -> A (in Ref. 5; CAA42620).
CONFLICT 167 167 T -> A (in Ref. 5; CAA42620).
CONFLICT 169 169 T -> A (in Ref. 5; CAA42620).
CONFLICT 176 176 Q -> R (in Ref. 5; CAA42620).
CONFLICT 184 184 A -> T (in Ref. 5; CAA42620).
CONFLICT 188 188 G -> R (in Ref. 5; CAA42620).
CONFLICT 195 195 N -> S (in Ref. 5; CAA42620).
CONFLICT 210 210 T -> A (in Ref. 5; CAA42620).
CONFLICT 292 292 K -> E (in Ref. 6; AAQ24858).
Back to Top